• Explore /
  • Poster
  • / Initial uptake of durvalumab with or without tremelimumab for advanced hepatocellular carcinoma in routine clinical practice: Preliminary results of the international DT-real study.

Initial uptake of durvalumab with or without tremelimumab for advanced hepatocellular carcinoma in routine clinical practice: Preliminary results of the international DT-real study.

Abstract Poster

Authors

null

Ciro Celsa

Department of Surgery and Cancer, Imperial College, Hammersmith Hospital, London, United Kingdom

Ciro Celsa , Naoshi Nishida , Ashwini Arvind , Susanna Varkey Ulahannan , Michael Li , Bernhard Scheiner , Claudia A.M. Fulgenzi , Antonio D'Alessio , Giulia F Manfredi , Bernardo Stefanini , Giuseppe Cabibbo , Alessio Cortellini , Matthias Pinter , Robin Kate Kelley , Paul Antoine El Tomb , Amit G. Singal , Masatoshi Kudo , David James Pinato

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Therapeutics

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 501)

DOI

10.1200/JCO.2024.42.3_suppl.501

Abstract #

501

Poster Bd #

D8

Abstract Disclosures

Similar Posters

First Author: Jia Fan

First Author: Sadahisa Ogasawara

First Author: M. Naomi Horiba

First Author: Oxana V. Crysler